A Quantum-Enhanced Precision Medicine Application to Support Data-Driven Clinical Decisions for the Personalized Treatment of Advanced Knee Osteoarthritis: The Development and Preliminary Validation of precisionKNEE_QNN
Nima Heidari, Stefano Olgiati, Davide Meloni, Federico Pirovano, Ali M. Noorani, MARK A. SLEVIN, Leonard Azamfirei
Background Quantum computing and quantum machine learning (QML) are promising experimental technologies that can improve precision medicine applications by reducing the computational complexity of algorithms driven by big, unstructured, real-world data. The clinical problem of knee osteoarthritis is that, although some novel therapies are safe and effective, the response is variable, and defining the characteristics of an individual who will respond remains a challenge. In this study, we tested a quantum neural network (QNN) application to support precision data-driven clinical decisions to select personalized treatments for advanced knee osteoarthritis. Methodology After obtaining patients' consent and Research Ethics Committee approval, we collected the clinicodemographic data before and after the treatment from 170 patients eligible for knee arthroplasty (Kellgren-Lawrence grade ≥3, Oxford Knee Score (OKS) ≤27, age ≥64 years, and idiopathic aetiology of arthritis) treated over a two-year period with a single injection of microfragmented fat. Gender classes were balanced (76 males and 94 females) to mitigate gender bias. A patient with an improvement ≥7 OKS was considered a responder. We trained our QNN classifier on a randomly selected training subset of 113 patients to classify responders from non-responders (73 responders and 40 non-responders) in pain and function at one year. Outliers were hidden from the training dataset but not from the validation set. Results We tested our QNN classifier on a randomly selected test subset of 57 patients (34 responders, 23 non-responders) including outliers. The no information rate was 0.59. Our application correctly classified 28 responders out of 34 and 6 non-responders out of 23 (sensitivity = 0.82, specificity = 0.26, F1 Statistic = 0.71). The positive and negative likelihood ratios were 1.11 and 0.68, respectively. The diagnostic odds ratio was 2. Conclusions Preliminary results on a small validation dataset showed that QML applied to data-driven clinical decisions for the personalized treatment of advanced knee osteoarthritis is a promising technology to reduce computational complexity and improve prognostic performance. Our results need further research validation with larger, real-world unstructured datasets, as well as clinical validation with an artificial intelligence clinical trial to test model efficacy, safety, clinical significance, and relevance at a public health level.
Background Quantum computing and quantum machine learning (QML) are promising experimental technologies that can improve precision medicine applications by reducing the computational complexity of algorithms driven by big, unstructured, real-world data. The clinical problem of knee osteoarthritis is that, although some novel therapies are safe and effective, the response is variable, and defining the characteristics of an individual who will respond remains a challenge. In this study, we tested a quantum neural network (QNN) application to support precision data-driven clinical decisions to select personalized treatments for advanced knee osteoarthritis. Methodology After obtaining patients' consent and Research Ethics Committee approval, we collected the clinicodemographic data before and after the treatment from 170 patients eligible for knee arthroplasty (Kellgren-Lawrence grade ≥3, Oxford Knee Score (OKS) ≤27, age ≥64 years, and idiopathic aetiology of arthritis) treated over a two-year period with a single injection of microfragmented fat. Gender classes were balanced (76 males and 94 females) to mitigate gender bias. A patient with an improvement ≥7 OKS was considered a responder. We trained our QNN classifier on a randomly selected training subset of 113 patients to classify responders from non-responders (73 responders and 40 non-responders) in pain and function at one year. Outliers were hidden from the training dataset but not from the validation set. Results We tested our QNN classifier on a randomly selected test subset of 57 patients (34 responders, 23 non-responders) including outliers. The no information rate was 0.59. Our application correctly classified 28 responders out of 34 and 6 non-responders out of 23 (sensitivity = 0.82, specificity = 0.26, F1 Statistic = 0.71). The positive and negative likelihood ratios were 1.11 and 0.68, respectively. The diagnostic odds ratio was 2. Conclusions Preliminary results on a small validation dataset showed that QML applied to data-driven clinical decisions for the personalized treatment of advanced knee osteoarthritis is a promising technology to reduce computational complexity and improve prognostic performance. Our results need further research validation with larger, real-world unstructured datasets, as well as clinical validation with an artificial intelligence clinical trial to test model efficacy, safety, clinical significance, and relevance at a public health level.
The rapid advancements in artificial intelligence (AI) and quantum computing have catalyzed an unprecedented shift in the methodologies utilized for healthcare diagnostics and treatment optimization. This research paper explores the integration of quantum neural networks (QNNs) with classical machine learning (ML) algorithms to enhance diagnostic accuracy, facilitate personalized treatment plans, and predict patient outcomes with a higher degree of precision. Quantum neural networks, leveraging the principles of quantum mechanics such as superposition, entanglement, and quantum parallelism, have demonstrated the potential to perform complex computations more efficiently than classical counterparts. When coupled with established machine learning algorithms, QNNs can overcome traditional limitations in data processing, enabling more sophisticated models capable of uncovering intricate patterns in large and high-dimensional datasets. Machine learning, with its vast applications in the medical field, has long been instrumental in improving diagnostics and tailoring treatment regimens to patient-specific characteristics. However, despite significant advancements, classical ML approaches face substantial challenges, particularly in terms of computational complexity and the ability to process large-scale, multi-modal healthcare data effectively. Quantum neural networks address these challenges by introducing quantum computational paradigms that facilitate exponentially faster processing, allowing for real-time analysis of vast and complex datasets. The synergy between QNNs and ML algorithms introduces novel approaches that are poised to revolutionize predictive analytics in healthcare, optimizing patient outcomes and enabling highly personalized treatment plans. A key aspect of integrating quantum neural networks into machine learning frameworks is the potential for improved precision in diagnostic systems. Traditional diagnostic procedures often rely on predefined models that may overlook nuanced correlations within patient data. Quantum neural networks, with their ability to represent and process data in a quantum space, provide a more robust framework that can adaptively learn from intricate relationships in patient information. For instance, QNNs can significantly enhance the efficacy of disease detection algorithms, such as those used for identifying early-stage cancers or predicting the onset of chronic conditions like diabetes and heart disease, by offering superior pattern recognition capabilities. Furthermore, QNNs combined with classical machine learning architectures facilitate the creation of hybrid models that harness the strengths of both approaches, leading to diagnostic tools that are not only more precise but also more adaptive to varied data sources. The integration of QNNs with machine learning extends beyond diagnostics to personalized treatment optimization. Traditional treatment planning methodologies, including rule-based and data-driven ML models, often face difficulties in accounting for the multifaceted nature of patient data and individual variability. Quantum neural networks enhance this process by leveraging quantum algorithms that provide an efficient search space for complex treatment optimization problems, allowing for a more detailed understanding of patient responses and potential treatment outcomes. The ability of QNNs to perform parallel processing enables the assessment of a wide range of treatment scenarios simultaneously, leading to more accurate predictions regarding patient reactions to specific drugs, therapies, or medical interventions. This facilitates an adaptive approach that can recommend personalized treatment regimens based on comprehensive patient profiles, ultimately enhancing patient outcomes and reducing the likelihood of adverse drug reactions. In addition to enhancing diagnostics and treatment recommendations, quantum neural networks show promise in forecasting patient outcomes by offering a more robust analysis of longitudinal patient data. Forecasting models that leverage the combined power of quantum and classical algorithms can process historical data more rapidly, allowing healthcare providers to anticipate potential health issues and intervene earlier. For example, predictive models utilizing QNNs can anticipate patient deterioration in critical care settings, facilitating timely interventions that mitigate risks and improve survival rates. Such predictive models can be instrumental in managing chronic diseases, monitoring recovery trajectories, and optimizing resource allocation within healthcare systems, thus contributing to overall efficiency and better resource management. Despite the promising capabilities of integrating QNNs with ML algorithms, there are notable challenges that need to be addressed to fully realize their potential. The practical implementation of quantum algorithms in a healthcare context faces hurdles related to hardware limitations, the need for high fidelity in quantum states, and the scalability of quantum systems to handle real-world clinical data. Additionally, the hybrid nature of combining classical and quantum approaches requires sophisticated algorithms that can bridge the gap between quantum computation and classical data processing pipelines. Solutions to these challenges may include advancements in quantum hardware, such as the development of more stable qubits and noise reduction techniques, as well as the optimization of hybrid algorithms that leverage both classical machine learning and quantum computing capabilities effectively. The exploration of quantum neural networks for healthcare applications also necessitates rigorous ethical considerations, particularly in ensuring data privacy and security. The incorporation of quantum computing must comply with healthcare data protection regulations, and quantum algorithms must be designed to maintain patient confidentiality while processing sensitive health data. Moreover, the interpretability of quantum models poses challenges that could hinder their acceptance in clinical practice. Advances in explainable AI and quantum algorithm transparency are crucial to foster trust among healthcare professionals and patients alike. Integration of quantum neural networks with classical machine learning models represents a transformative approach that could significantly advance healthcare diagnostics, personalized treatment strategies, and patient outcome prediction. By harnessing the computational advantages offered by quantum systems and the flexibility of machine learning algorithms, healthcare applications can achieve a new level of precision and adaptability. Despite current challenges, continued research into quantum algorithms, quantum hardware development, and hybrid computational models promises substantial strides in overcoming these limitations. The synergy between QNNs and ML algorithms could ultimately lead to more effective, personalized, and efficient healthcare solutions, ushering in a new era of data-driven medical care characterized by increased diagnostic accuracy and improved treatment outcomes. As the field evolves, interdisciplinary collaboration between quantum physicists, computer scientists, and healthcare professionals will be vital to unlock the full potential of these innovative computational techniques and bring them to mainstream clinical use.
The advent of quantum computing has introduced significant potential to revolutionize healthcare through quantum neural networks (QNNs), offering unprecedented capabilities in processing and analyzing multimodal medical data. Traditional computational methods, including classical machine learning models, face challenges when handling the complex, high-dimensional, and often heterogeneous nature of medical data. Quantum neural networks, leveraging quantum mechanics’ fundamental principles, provide a robust framework capable of handling such data with enhanced accuracy and efficiency. This paper investigates the transformative role of QNNs in healthcare diagnostics, treatment pathway optimization, and long-term prognostic analytics, emphasizing their potential to elevate current medical practices to new heights. We begin by providing an overview of the theoretical foundation of quantum computing and the specific mechanisms by which quantum neural networks operate, detailing the principles of quantum superposition, entanglement, and quantum parallelism. These principles empower QNNs to perform computations that are infeasible for classical counterparts, thereby paving the way for deeper, multidimensional insights into patient data. The integration of QNNs into healthcare presents opportunities for significantly enhancing diagnostic accuracy, particularly when analyzing multimodal inputs such as medical images, genomic data, electronic health records, and physiological signals. The capability of QNNs to operate on qubits, which can exist in multiple states simultaneously, enables them to identify complex patterns that classical models may overlook. Through the use of quantum circuits designed for classification and regression tasks, QNNs can facilitate more precise disease identification, including rare conditions that require intricate data synthesis for accurate diagnosis. Moreover, the inherent parallelism of quantum algorithms allows for faster data processing, which could lead to more timely diagnoses and better patient outcomes. This paper delves into the practical application of QNNs in devising and optimizing treatment pathways. The precision with which QNNs analyze patient-specific data can inform personalized medicine approaches, guiding tailored treatment plans based on real-time patient feedback and evolving clinical parameters. We explore how QNNs can leverage their ability to integrate diverse data sources—such as genetic information, medical history, and lifestyle factors—to model patient responses to different treatments with a higher degree of accuracy. This modeling is essential for predicting potential drug interactions, side effects, and overall efficacy, leading to improved patient care by minimizing trial-and-error approaches and reducing healthcare costs. Long-term prognostic analysis, a critical component of chronic disease management and preventive healthcare, also stands to benefit from the integration of quantum neural networks. By synthesizing longitudinal data and identifying temporal trends, QNNs can uncover latent predictive factors that influence the progression of diseases. The paper presents an analysis of how QNNs can provide accurate predictions for patient outcomes over extended periods, taking into account not only individual health records but also epidemiological data and environmental influences. This type of analysis can assist healthcare providers in developing proactive care strategies that are both more effective and resource-efficient. The potential of QNNs to enhance prognostic assessments is not limited to predicting survival rates but extends to forecasting disease remission and recurrence patterns, contributing to informed decision-making in clinical settings. The paper further highlights current challenges and limitations in implementing QNNs in practical healthcare scenarios. These include technological constraints such as qubit coherence times, quantum error correction, and the scalability of quantum algorithms. The integration of quantum hardware with classical infrastructure also poses significant hurdles, requiring robust hybrid systems that can bridge the gap between quantum and classical data processing. We examine ongoing research efforts aimed at overcoming these challenges, including advancements in quantum algorithm development, quantum hardware improvements, and the development of hybrid quantum-classical architectures that can maximize computational power while mitigating current limitations. Furthermore, ethical considerations related to patient data privacy and security are scrutinized, given the novel nature of quantum computing and the sensitivity of medical data. Ensuring data security in quantum-enhanced healthcare systems is paramount, as the encryption methods that safeguard classical systems may not be sufficient against quantum threats. We discuss the integration of quantum cryptography techniques that can complement QNN applications, providing a comprehensive approach to data protection that aligns with healthcare regulations. This paper concludes by outlining future directions for quantum neural network applications in healthcare. The potential for QNNs to revolutionize the field hinges not only on advancements in quantum hardware but also on the development of interdisciplinary research and collaboration between quantum physicists, computer scientists, and healthcare professionals. The roadmap for widespread adoption includes education and training to equip healthcare practitioners with the necessary skills to work with quantum-enhanced systems, as well as strategic partnerships aimed at integrating quantum technologies into existing healthcare infrastructures. The implications for global health are profound, as quantum neural networks stand to make healthcare more accessible, efficient, and personalized. By transforming diagnostics, optimizing treatment pathways, and providing predictive insights, QNNs could catalyze a paradigm shift in the way medical services are delivered, enhancing both the quality of care and patient outcomes on a global scale.
Background and Objectives: Quantum machine learning (QML) leverages quantum computing principles to enhance artificial intelligence applications in health care. We aimed to conduct a systematic literature review following Preferred Reporting Items for Systematic reviews and Meta-Analyses 2020 guidelines to evaluate QML and quantum-assisted artificial intelligence (AI) applications in orthopedics and medicine.Materials and Methods: Comprehensive searches were performed across SciSpace, Google Scholar, and PubMed, yielding 1,068 initial records. After deduplication (819 unique records), abstract screening (threshold ≥4.0), and full-text screening (threshold ≥4.5), 97 studies met the inclusion criteria. Screening criteria included medical and orthopedic application, quantum-enhanced AI intervention, comparative performance evaluation, and clinical/computational outcome reporting. Data extraction focused on study design, quantum ML methods, medical application domains, key findings, performance comparisons, and clinical implications. Prediction model Risk of Bias Assessment Tool (PROBAST) guidelines were used to assess risk of the studies that report superior performance of QML over conventional ML or others.Results: The 97 included studies demonstrated diverse applications of QML across multiple medical domains, including orthopedics, oncology, cardiology, neurology, ophthalmology, and other specialties. Quantum approaches included quantum neural networks, quantum support vector machines, variational quantum classifiers, hybrid quantum-classical models, quantum transfer learning, and quantum federated learning. Performance comparisons consistently showed quantum-enhanced methods achieving comparable or superior accuracy to classical approaches. The overall risk of bias for all 11 studies with superior performance was determined as high risk using PROBAST guidelines.Conclusions: QML demonstrates significant promise for enhancing diagnostic accuracy, treatment optimization, and predictive analytics in orthopedics and medicine. Although current implementations face challenges related to hardware limitations, scalability, and clinical validation requirements, the evidence suggests that hybrid quantum-classical approaches offer practical pathways toward clinical adoption with the awareness of reports with high risk of bias. Future studies should focus on large-scale clinical trials and real-world validation of QML.
By facilitating quicker and more precise analysis of intricate biological data, the union of quantum computing and Artificial Intelligence (AI) may transform genomic medicine and drug discovery altogether. The study suggests a model for artificial intelligence with quantum-enhanced acceleration based on hybrid quantum-classical models in order to speed up drug discovery and customize therapies. It utilizes deep learning models and Quantum Machine Learning (QML) techniques to analyze patient-specific data, protein structures, and genetic sequences. Large genomic and clinical data sets are processed by conventional deep learning models, while the quantum component carries out efficient data encoding and optimization processes. As compared to other traditional AI-based approaches, the proposed model performs a 30% improved drug target identification when evaluated against more than 1,000 genetic sequences and related clinical outcomes. The hybrid model was as accurate as 98.4% in its prediction and was more accurate than the conventional AI techniques including random forests (accuracy: 91.3%) and gradient boosting machines (accuracy: 93.7%). The methodology also produced an F1-score of 0.95 with accuracy and recall scores of 96.1% and 94.7%, respectively. These results demonstrate how quantum-enhanced AI can reduce the time for computation and improve the accuracy of genomic data analysis, driving significant progress toward personalized therapy and drug development.
Quantum machine learning takes advantage of features such as quantum computing superposition and entanglement to enable better performance of machine learning models. In this paper, we first propose an improved hybrid quantum convolutional neural network (HQCNN) model. The HQCNN model was used to pre-train brain tumor dataset (MRI) images. Next, the quantum classical transfer learning (QCTL) approach is used to fine-tune and extract features based on pre-trained weights. A hybrid quantum convolutional network structure was used to test the osteoarthritis of the knee dataset (OAI) and to quantitatively evaluate standard metrics to verify the robustness of the classifier. The final experimental results show that the QCTL method can effectively classify knee osteoarthritis with a classification accuracy of 98.36%. The quantum-to-classical transfer learning method improves classification accuracy by 1.08%. How to use different coding techniques in HQCNN models applied to medical image analysis is also a future research direction.
Background Artificial Intelligence (AI) incorporation within healthcare applications has significantly helped in the improvement of healthcare diagnostics, patient forecasting, and clinical decision-making. The steady growing of medical data in terms of quantity, quality, and dimension poses more significant problems for traditional AI methods in terms of size, time, and computational efficiency. However, classical machine learning models often struggle with high-dimensional, imbalanced, and heterogeneous medical datasets, which limits their scalability and generalizability. The Quantum Artificial Intelligence (QAI) model, which combines quantum computing and machine learning in a complementary way, has emerged as one of the main trends to defeat these problems. This complementary approach is gaining more popularity, with the most advanced work being developed in this area, as it offers a fundamental explanation of current complexities and the underlying principles and their applications. Methodology This paper begins with the basic concepts of quantum computing and where it overlaps with AI. It then moves to a comparative approach, discussing various quantum machine learning algorithms such as quantum support vector machines, quantum neural networks, and variational quantum circuits. A comparative evaluation of quantum support vector machine, variational quantum classifier, quantum neural network, quantum K-means, and quantum Boltzmann machine is conducted using the Pima Indians Diabetes dataset to assess model behaviour and performance under standard metrics. Further detail is provided on the theoretical and practical implications of QAI in medical imaging, genomics, electronic health records, and drug discovery. Additionally, this paper examines platforms, tools, and quantum hardware used for QAI research, and discusses unique challenges currently faced in quantum technology. Results Unlike prior surveys that primarily provide conceptual overviews, this paper uniquely combines a comprehensive review with practical benchmarking of multiple quantum machine learning models on a benchmark medical dataset. This provides comparative insights into algorithmic performance under real-world constraints, particularly in relation to high-dimensional medical data, genomic data, electronic health records with large number of clinical attributes, radiology images, etc. In this study, dimensionality arises from multivariate clinical features encoded into quantum feature maps and the limitations of current quantum systems. Conclusion This paper aims to serve as a starting point for researchers and practitioners interested in the potential of quantum-enhanced AI to transform health data analytics. By identifying current limitations, evaluating the performance of emerging quantum machine learning approaches, and outlining gaps in the literature, the paper highlights future research directions necessary to advance QAI in healthcare. Overall, the findings outline both the potential and practical constraints of quantum models, offering a foundation for future work toward scalable, clinically applicable QAI solutions.